Health care costs associated with acute asthma: a economic analysis Source: Eur Respir J 2002; 20: Suppl. 38, 42s Year: 2002
Health care claims analysis to quantify the burden of moderate-to-severe asthma Source: Annual Congress 2012 - Looking at the cost effectiveness of asthma and COPD treatment by novel drugs and improved management Year: 2012
Cost of health care associated with workplace exacerbation of asthma Source: Eur Respir J 2007; 30: Suppl. 51, 157s Year: 2007
Health care utilization and costs of asthma and COPD in the Netherlands Source: Eur Respir J 2005; 26: Suppl. 49, 383s Year: 2005
Health services utilisation by COPD patients in clinical stability and during an exacerbation Source: Eur Respir J 2003; 22: Suppl. 45, 217s Year: 2003
Predictive value of annual costs on 3-year mortality in COPD Source: International Congress 2015 – Patient health gains related to the economic effectiveness of disease management programmes Year: 2015
Health care costs in COPD patients with severe respiratory failure: a prospective analysis Source: Annual Congress 2009 - Organisation of care for individuals with chronic respiratory disease Year: 2009
Health service utilisation associated with chronic breathlessness: random population sample Source: ERJ Open Res, 7 (4) 00415-2021; 10.1183/23120541.00415-2021 Year: 2021
Are acute asthma admissions preventable with improved patient education? Source: Annual Congress 2013 –Treatment and management of asthma in primary care Year: 2013
Cost and effectiveness of integrated care intervention on the patients with COPD Source: Annual Congress 2013 –The best posters in chronic care Year: 2013
Long-term evaluation of seasonal out-of-pocket medical costs in patients with chronic respiratory disease based on a survey Source: Annual Congress 2013 –Respiratory nursing care: assessment, interventions and education Year: 2013
Health status measurement predicts exacerbations and resource utilization Source: Eur Respir J 2001; 18: Suppl. 33, 461s Year: 2001
External validation of exacerbation and mortality outcomes of health economic decision models for COPD Source: International Congress 2016 – Prevalence, prognosis, and risk factors of COPD Year: 2016
Association of COPD symptomatic burden with healthcare resource utilization and impairment on work and activity Source: International Congress 2016 – Asthma, COPD, and ACOS: physical activity, dietary aspects, and diseases burden Year: 2016
Cost and effectiveness of 2 years integrated care intervention in COPD Source: International Congress 2015 – COPD: chronic disease and comorbidities Year: 2015
Health outcomes assessment and economic evaluation in COPD: challenges and opportunities Source: Eur Respir J 2003; 21: 1S-3S Year: 2003
COPD readmissions in an urban environment: Health service factors Source: International Congress 2015 – Diagnosing and management of COPD in primary care Year: 2015
COPD admissions and inhaled medications: Escalating prescription costs but no evidence of effect. A national primary care study Source: Annual Congress 2013 –Quality of diagnosis and assessment in primary care Year: 2013
An outreaching model of tertiary difficult asthma care reduces adverse asthma outcomes and healthcare utilisation costs Source: Eur Respir J 2016; 47:1857-1860 Year: 2016
Evaluating a developmental care for the family rearing children with chronic asthma on the asthma-related quality of life and lung function Source: International Congress 2016 – The wide spectrum of respiratory nursing research and practice: across all ages and diseases Year: 2016